| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Anemia | 13 | 2021 | 789 | 3.92 | Why? |
| Blood Transfusion | 10 | 2020 | 1399 | 2.00 | Why? |
| Erythrocyte Transfusion | 6 | 2019 | 386 | 1.69 | Why? |
| Operative Blood Salvage | 3 | 2020 | 19 | 1.19 | Why? |
| Preoperative Care | 6 | 2021 | 1515 | 0.98 | Why? |
| Blood Loss, Surgical | 4 | 2019 | 211 | 0.95 | Why? |
| Blood Transfusion, Autologous | 1 | 2019 | 37 | 0.77 | Why? |
| Salvage Therapy | 1 | 2020 | 417 | 0.69 | Why? |
| Surgical Procedures, Operative | 5 | 2021 | 2662 | 0.69 | Why? |
| Anesthesiology | 2 | 2019 | 1163 | 0.68 | Why? |
| Ischemic Preconditioning | 4 | 2018 | 43 | 0.67 | Why? |
| Blood Coagulation Disorders, Inherited | 1 | 2017 | 82 | 0.63 | Why? |
| Hemoglobins | 6 | 2019 | 958 | 0.63 | Why? |
| Postoperative Hemorrhage | 1 | 2017 | 183 | 0.60 | Why? |
| Pregnancy Complications, Hematologic | 1 | 2017 | 114 | 0.59 | Why? |
| Peptide Fragments | 3 | 2020 | 2075 | 0.56 | Why? |
| Blood Banks | 1 | 2020 | 535 | 0.54 | Why? |
| Blood Specimen Collection | 1 | 2018 | 387 | 0.53 | Why? |
| Arthroplasty, Replacement, Knee | 1 | 2019 | 363 | 0.53 | Why? |
| Critical Illness | 8 | 2021 | 17281 | 0.50 | Why? |
| Blood Coagulation Tests | 1 | 2018 | 855 | 0.49 | Why? |
| Blood Component Transfusion | 1 | 2017 | 740 | 0.46 | Why? |
| Coronary Artery Bypass | 5 | 2018 | 629 | 0.46 | Why? |
| Disasters | 1 | 2020 | 760 | 0.43 | Why? |
| Ischemia | 1 | 2019 | 901 | 0.42 | Why? |
| Xenon | 2 | 2018 | 27 | 0.37 | Why? |
| Preanesthetic Medication | 1 | 2007 | 6 | 0.36 | Why? |
| Perioperative Care | 1 | 2019 | 1329 | 0.35 | Why? |
| Blood Coagulation Disorders | 2 | 2020 | 2040 | 0.35 | Why? |
| Orthopedic Procedures | 1 | 2019 | 1231 | 0.35 | Why? |
| Evidence-Based Medicine | 2 | 2017 | 3228 | 0.33 | Why? |
| Disaster Planning | 1 | 2020 | 1680 | 0.32 | Why? |
| Blood Donors | 1 | 2020 | 2956 | 0.31 | Why? |
| Postoperative Complications | 4 | 2018 | 5861 | 0.31 | Why? |
| Anemia, Iron-Deficiency | 2 | 2019 | 210 | 0.31 | Why? |
| Adrenomedullin | 2 | 2018 | 217 | 0.30 | Why? |
| Ambulatory Care Facilities | 1 | 2017 | 2063 | 0.29 | Why? |
| Germany | 9 | 2021 | 9196 | 0.29 | Why? |
| Anesthesia, Obstetrical | 2 | 2020 | 230 | 0.29 | Why? |
| Fibrin Fibrinogen Degradation Products | 1 | 2020 | 5993 | 0.27 | Why? |
| Protein Precursors | 2 | 2018 | 425 | 0.27 | Why? |
| Extracorporeal Membrane Oxygenation | 1 | 2020 | 5002 | 0.23 | Why? |
| Anesthesia, Intravenous | 2 | 2018 | 37 | 0.22 | Why? |
| Deficiency Diseases | 1 | 2021 | 66 | 0.22 | Why? |
| Cardiac Surgical Procedures | 4 | 2019 | 1931 | 0.22 | Why? |
| Vitamins | 2 | 2021 | 1208 | 0.21 | Why? |
| Gallbladder Diseases | 1 | 2020 | 40 | 0.21 | Why? |
| Calcifediol | 1 | 2021 | 191 | 0.20 | Why? |
| Clinical Trials, Phase IV as Topic | 1 | 2019 | 75 | 0.19 | Why? |
| Respiration, Artificial | 4 | 2021 | 22116 | 0.19 | Why? |
| Receptors, Lysosphingolipid | 1 | 2018 | 25 | 0.19 | Why? |
| Needs Assessment | 2 | 2020 | 2352 | 0.19 | Why? |
| Ascitic Fluid | 1 | 2020 | 169 | 0.18 | Why? |
| Arachidonate 5-Lipoxygenase | 1 | 2018 | 51 | 0.18 | Why? |
| Antiparasitic Agents | 1 | 2021 | 267 | 0.18 | Why? |
| Maltose | 1 | 2018 | 50 | 0.18 | Why? |
| Methyl Ethers | 1 | 2017 | 22 | 0.18 | Why? |
| Head-Down Tilt | 1 | 2017 | 13 | 0.18 | Why? |
| Cholecystectomy | 1 | 2020 | 198 | 0.18 | Why? |
| Lysophospholipids | 1 | 2018 | 74 | 0.17 | Why? |
| Cholecalciferol | 1 | 2021 | 246 | 0.17 | Why? |
| Ischemic Preconditioning, Myocardial | 1 | 2017 | 18 | 0.17 | Why? |
| Multiple Organ Failure | 2 | 2018 | 1724 | 0.17 | Why? |
| Antioxidants | 2 | 2018 | 1593 | 0.17 | Why? |
| Ventilators, Mechanical | 2 | 2020 | 2193 | 0.17 | Why? |
| Sphingosine | 1 | 2018 | 101 | 0.17 | Why? |
| Proteinuria | 1 | 2021 | 474 | 0.17 | Why? |
| Humans | 55 | 2021 | 930598 | 0.17 | Why? |
| Oxytocics | 1 | 2017 | 47 | 0.17 | Why? |
| Ferric Compounds | 1 | 2018 | 136 | 0.17 | Why? |
| Micronutrients | 1 | 2021 | 310 | 0.17 | Why? |
| Heart Valves | 1 | 2017 | 52 | 0.17 | Why? |
| Evaluation Studies as Topic | 1 | 2018 | 391 | 0.17 | Why? |
| Sepsis | 3 | 2018 | 3517 | 0.16 | Why? |
| Cell-Derived Microparticles | 1 | 2017 | 134 | 0.16 | Why? |
| Selenium | 1 | 2021 | 412 | 0.15 | Why? |
| Postpartum Hemorrhage | 1 | 2017 | 144 | 0.15 | Why? |
| Hemostatics | 1 | 2017 | 142 | 0.15 | Why? |
| Propofol | 1 | 2018 | 172 | 0.15 | Why? |
| Aged | 23 | 2021 | 215776 | 0.15 | Why? |
| Pneumonia, Viral | 9 | 2020 | 243684 | 0.15 | Why? |
| Reperfusion Injury | 1 | 2017 | 178 | 0.15 | Why? |
| Blood Coagulation Factors | 1 | 2017 | 223 | 0.15 | Why? |
| Coronavirus Infections | 9 | 2020 | 253789 | 0.15 | Why? |
| Anesthesia, General | 1 | 2020 | 470 | 0.15 | Why? |
| Intensive Care Units | 7 | 2021 | 29594 | 0.14 | Why? |
| Aspergillus | 1 | 2018 | 347 | 0.14 | Why? |
| Transfusion Reaction | 1 | 2017 | 245 | 0.14 | Why? |
| Internationality | 2 | 2018 | 3297 | 0.14 | Why? |
| Anesthesia, Cardiac Procedures | 1 | 2017 | 145 | 0.14 | Why? |
| Troponin I | 3 | 2018 | 1298 | 0.14 | Why? |
| Organ Dysfunction Scores | 2 | 2018 | 1475 | 0.14 | Why? |
| Machine Learning | 2 | 2021 | 4395 | 0.14 | Why? |
| Upper Extremity | 1 | 2017 | 193 | 0.14 | Why? |
| Drug Resistance | 1 | 2017 | 395 | 0.14 | Why? |
| Treatment Outcome | 7 | 2021 | 51732 | 0.14 | Why? |
| Female | 29 | 2021 | 380317 | 0.13 | Why? |
| Arthroplasty, Replacement, Hip | 1 | 2019 | 403 | 0.13 | Why? |
| Male | 29 | 2021 | 367725 | 0.13 | Why? |
| Nitric Oxide | 1 | 2020 | 769 | 0.13 | Why? |
| Zinc | 1 | 2021 | 817 | 0.13 | Why? |
| Critical Care | 6 | 2020 | 14081 | 0.13 | Why? |
| Efficiency | 1 | 2017 | 420 | 0.13 | Why? |
| Cause of Death | 4 | 2021 | 4823 | 0.13 | Why? |
| Neoplasms | 2 | 2018 | 17251 | 0.12 | Why? |
| Renal Replacement Therapy | 2 | 2021 | 1530 | 0.12 | Why? |
| Prospective Studies | 9 | 2019 | 43301 | 0.12 | Why? |
| Ascorbic Acid | 1 | 2018 | 676 | 0.12 | Why? |
| Cardiopulmonary Bypass | 3 | 2018 | 158 | 0.12 | Why? |
| Ivermectin | 1 | 2021 | 973 | 0.11 | Why? |
| Middle Aged | 22 | 2021 | 270681 | 0.11 | Why? |
| Multicenter Studies as Topic | 1 | 2019 | 2437 | 0.11 | Why? |
| Erythrocytes | 1 | 2017 | 617 | 0.11 | Why? |
| Intestines | 1 | 2017 | 817 | 0.11 | Why? |
| Invasive Pulmonary Aspergillosis | 1 | 2018 | 634 | 0.11 | Why? |
| Hemodynamics | 3 | 2020 | 1562 | 0.10 | Why? |
| Recovery of Function | 1 | 2020 | 2461 | 0.10 | Why? |
| Time Factors | 5 | 2021 | 31397 | 0.10 | Why? |
| Randomized Controlled Trials as Topic | 5 | 2021 | 10649 | 0.10 | Why? |
| Melatonin | 1 | 2017 | 578 | 0.10 | Why? |
| Pandemics | 11 | 2021 | 389249 | 0.10 | Why? |
| DNA, Viral | 1 | 2020 | 2521 | 0.10 | Why? |
| Patient Readmission | 1 | 2019 | 1543 | 0.10 | Why? |
| Pneumonia, Ventilator-Associated | 1 | 2017 | 861 | 0.10 | Why? |
| Bronchoalveolar Lavage Fluid | 1 | 2018 | 2309 | 0.09 | Why? |
| Dietary Supplements | 1 | 2021 | 2251 | 0.09 | Why? |
| Iron | 3 | 2019 | 619 | 0.09 | Why? |
| Aspirin | 1 | 2017 | 1043 | 0.09 | Why? |
| Clorazepate Dipotassium | 1 | 2007 | 1 | 0.09 | Why? |
| Water-Electrolyte Balance | 1 | 2008 | 136 | 0.09 | Why? |
| Videoconferencing | 1 | 2020 | 2081 | 0.09 | Why? |
| Electronic Health Records | 1 | 2021 | 3492 | 0.09 | Why? |
| Feasibility Studies | 1 | 2017 | 3467 | 0.08 | Why? |
| Midazolam | 1 | 2007 | 79 | 0.08 | Why? |
| Risk Assessment | 3 | 2020 | 25439 | 0.08 | Why? |
| Cesarean Section | 1 | 2017 | 2089 | 0.08 | Why? |
| Betacoronavirus | 7 | 2020 | 204454 | 0.08 | Why? |
| Adrenal Glands | 1 | 2007 | 98 | 0.08 | Why? |
| Anti-Anxiety Agents | 1 | 2007 | 139 | 0.08 | Why? |
| Clinical Decision-Making | 1 | 2020 | 3755 | 0.08 | Why? |
| Renal Insufficiency, Chronic | 1 | 2021 | 2654 | 0.08 | Why? |
| Aged, 80 and over | 8 | 2021 | 88759 | 0.08 | Why? |
| Sympathetic Nervous System | 1 | 2007 | 111 | 0.08 | Why? |
| Patient Positioning | 1 | 2017 | 1505 | 0.08 | Why? |
| Fluid Therapy | 1 | 2011 | 628 | 0.08 | Why? |
| Pilot Projects | 4 | 2020 | 5182 | 0.08 | Why? |
| Frailty | 1 | 2018 | 1432 | 0.08 | Why? |
| Monitoring, Intraoperative | 1 | 2007 | 140 | 0.08 | Why? |
| Consensus | 2 | 2018 | 6345 | 0.08 | Why? |
| Mobile Applications | 1 | 2021 | 3032 | 0.07 | Why? |
| Conscious Sedation | 1 | 2007 | 222 | 0.07 | Why? |
| Epinephrine | 1 | 2007 | 323 | 0.07 | Why? |
| Emergencies | 1 | 2020 | 4095 | 0.07 | Why? |
| Biomarkers | 5 | 2019 | 23361 | 0.07 | Why? |
| Blood Coagulation | 1 | 2017 | 2768 | 0.07 | Why? |
| Retrospective Studies | 9 | 2021 | 105322 | 0.07 | Why? |
| Stroke Volume | 2 | 2011 | 2153 | 0.07 | Why? |
| Europe | 1 | 2020 | 12702 | 0.06 | Why? |
| Point-of-Care Systems | 1 | 2017 | 2955 | 0.06 | Why? |
| Quality of Life | 3 | 2021 | 9820 | 0.06 | Why? |
| Risk Factors | 4 | 2020 | 71621 | 0.06 | Why? |
| Polymerase Chain Reaction | 1 | 2018 | 6740 | 0.06 | Why? |
| Blood Pressure | 3 | 2011 | 2198 | 0.06 | Why? |
| Interleukin-10 | 2 | 2020 | 1409 | 0.06 | Why? |
| Selenoprotein P | 1 | 2021 | 40 | 0.06 | Why? |
| 25-Hydroxyvitamin D 2 | 1 | 2021 | 28 | 0.06 | Why? |
| Elective Surgical Procedures | 1 | 2020 | 5338 | 0.06 | Why? |
| Double-Blind Method | 2 | 2017 | 5988 | 0.06 | Why? |
| Nervous System Diseases | 1 | 2020 | 4092 | 0.06 | Why? |
| Hospital Mortality | 3 | 2020 | 22087 | 0.06 | Why? |
| Reproducibility of Results | 1 | 2018 | 11304 | 0.06 | Why? |
| Societies, Medical | 1 | 2017 | 6907 | 0.05 | Why? |
| Prognosis | 3 | 2021 | 32490 | 0.05 | Why? |
| Ecological Momentary Assessment | 1 | 2021 | 139 | 0.05 | Why? |
| Heart Arrest | 1 | 2011 | 1239 | 0.05 | Why? |
| Growth Differentiation Factor 15 | 1 | 2020 | 89 | 0.05 | Why? |
| Positive-Pressure Respiration | 1 | 2008 | 1160 | 0.05 | Why? |
| Area Under Curve | 2 | 2018 | 2564 | 0.05 | Why? |
| Electroencephalography | 1 | 2007 | 1242 | 0.05 | Why? |
| Disease Transmission, Infectious | 2 | 2020 | 9044 | 0.05 | Why? |
| Hospitals | 1 | 2020 | 11793 | 0.05 | Why? |
| Hematinics | 1 | 2019 | 48 | 0.05 | Why? |
| Anti-Inflammatory Agents | 1 | 2018 | 6153 | 0.05 | Why? |
| Ceftriaxone | 1 | 2021 | 365 | 0.05 | Why? |
| Cardiac Output | 2 | 2011 | 183 | 0.05 | Why? |
| Inflammation | 2 | 2021 | 13255 | 0.05 | Why? |
| Arachidonic Acid | 1 | 2018 | 90 | 0.05 | Why? |
| Protein Kinase C | 1 | 2018 | 58 | 0.05 | Why? |
| Glycogen Synthase Kinase 3 beta | 1 | 2018 | 45 | 0.05 | Why? |
| Pregnancy | 2 | 2020 | 23879 | 0.05 | Why? |
| Intramolecular Oxidoreductases | 1 | 2018 | 38 | 0.05 | Why? |
| Macrophage Migration-Inhibitory Factors | 1 | 2018 | 39 | 0.04 | Why? |
| Placebos | 1 | 2021 | 629 | 0.04 | Why? |
| Incidence | 2 | 2017 | 25622 | 0.04 | Why? |
| Galactose | 1 | 2018 | 201 | 0.04 | Why? |
| Deoxyguanosine | 1 | 2017 | 19 | 0.04 | Why? |
| Cardiopulmonary Resuscitation | 1 | 2011 | 1876 | 0.04 | Why? |
| Tourniquets | 1 | 2017 | 20 | 0.04 | Why? |
| Fatty Acid-Binding Proteins | 1 | 2017 | 93 | 0.04 | Why? |
| Age Factors | 1 | 2019 | 21039 | 0.04 | Why? |
| Adult | 8 | 2021 | 244371 | 0.04 | Why? |
| Glutathione Peroxidase | 1 | 2017 | 83 | 0.04 | Why? |
| Mannans | 1 | 2018 | 218 | 0.04 | Why? |
| ROC Curve | 3 | 2018 | 6024 | 0.04 | Why? |
| Post-Exposure Prophylaxis | 1 | 2021 | 472 | 0.04 | Why? |
| Anesthetics, Inhalation | 1 | 2017 | 82 | 0.04 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.04 | Why? |
| Substrate Specificity | 1 | 2018 | 639 | 0.04 | Why? |
| Oxidative Stress | 2 | 2018 | 2050 | 0.04 | Why? |
| Superoxide Dismutase | 1 | 2017 | 155 | 0.04 | Why? |
| Calcitonin | 1 | 2018 | 201 | 0.04 | Why? |
| beta-Glucans | 1 | 2018 | 176 | 0.04 | Why? |
| Regional Blood Flow | 1 | 2017 | 172 | 0.04 | Why? |
| Blood Preservation | 1 | 2017 | 191 | 0.04 | Why? |
| Nervous System | 1 | 2018 | 303 | 0.04 | Why? |
| Comorbidity | 1 | 2020 | 34796 | 0.04 | Why? |
| Platelet Function Tests | 1 | 2017 | 231 | 0.04 | Why? |
| Practice Guidelines as Topic | 1 | 2020 | 15421 | 0.04 | Why? |
| Interleukins | 1 | 2021 | 762 | 0.04 | Why? |
| Intention to Treat Analysis | 1 | 2017 | 673 | 0.04 | Why? |
| APACHE | 1 | 2018 | 682 | 0.04 | Why? |
| Proportional Hazards Models | 2 | 2018 | 6543 | 0.04 | Why? |
| Bias | 1 | 2021 | 1109 | 0.04 | Why? |
| Cell Communication | 1 | 2017 | 396 | 0.04 | Why? |
| Thromboplastin | 1 | 2017 | 275 | 0.04 | Why? |
| Lactic Acid | 1 | 2018 | 393 | 0.04 | Why? |
| DNA Damage | 1 | 2017 | 285 | 0.03 | Why? |
| Administration, Inhalation | 1 | 2020 | 1647 | 0.03 | Why? |
| Administration, Intravenous | 1 | 2018 | 1115 | 0.03 | Why? |
| Pregnancy Complications, Infectious | 1 | 2020 | 11559 | 0.03 | Why? |
| Single-Blind Method | 1 | 2017 | 1283 | 0.03 | Why? |
| Antibodies, Neutralizing | 1 | 2020 | 25288 | 0.03 | Why? |
| Calcium | 1 | 2018 | 708 | 0.03 | Why? |
| Platelet Activation | 1 | 2017 | 660 | 0.03 | Why? |
| C-Reactive Protein | 2 | 2021 | 7972 | 0.03 | Why? |
| Delphi Technique | 1 | 2017 | 1257 | 0.03 | Why? |
| Gastrointestinal Hemorrhage | 1 | 2019 | 669 | 0.03 | Why? |
| Infectious Disease Transmission, Professional-to-Patient | 1 | 2020 | 1316 | 0.03 | Why? |
| Reactive Oxygen Species | 1 | 2018 | 1136 | 0.03 | Why? |
| Swine, Miniature | 1 | 2011 | 33 | 0.03 | Why? |
| Troponin | 1 | 2018 | 1058 | 0.03 | Why? |
| Central Venous Pressure | 1 | 2011 | 24 | 0.03 | Why? |
| Troponin T | 1 | 2017 | 771 | 0.03 | Why? |
| Immune System | 1 | 2021 | 1479 | 0.03 | Why? |
| Interleukin-8 | 1 | 2017 | 964 | 0.03 | Why? |
| Antibodies, Viral | 2 | 2020 | 51949 | 0.03 | Why? |
| Hip Fractures | 1 | 2019 | 667 | 0.03 | Why? |
| Swine | 2 | 2011 | 3352 | 0.03 | Why? |
| Infection Control | 1 | 2020 | 23131 | 0.03 | Why? |
| Interleukin-6 | 2 | 2020 | 7522 | 0.03 | Why? |
| Myocardial Ischemia | 1 | 2017 | 781 | 0.03 | Why? |
| Cardiovascular System | 1 | 2018 | 750 | 0.03 | Why? |
| Thermodilution | 1 | 2008 | 62 | 0.02 | Why? |
| Immunoglobulin A | 1 | 2020 | 3567 | 0.02 | Why? |
| Patient Care | 1 | 2020 | 1664 | 0.02 | Why? |
| Random Allocation | 1 | 2011 | 773 | 0.02 | Why? |
| Kaplan-Meier Estimate | 1 | 2018 | 4260 | 0.02 | Why? |
| Lymphopenia | 1 | 2020 | 2669 | 0.02 | Why? |
| Adaptation, Physiological | 1 | 2011 | 359 | 0.02 | Why? |
| Antiviral Agents | 1 | 2021 | 41703 | 0.02 | Why? |
| Body Mass Index | 1 | 2021 | 4306 | 0.02 | Why? |
| Echocardiography, Transesophageal | 1 | 2011 | 447 | 0.02 | Why? |
| Mice, Inbred C57BL | 1 | 2018 | 5542 | 0.02 | Why? |
| Oxygen | 1 | 2021 | 3715 | 0.02 | Why? |
| Vitamin D Deficiency | 1 | 2021 | 1782 | 0.02 | Why? |
| Protein Domains | 1 | 2020 | 6563 | 0.02 | Why? |
| Hospitals, University | 1 | 2020 | 4173 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2021 | 7268 | 0.02 | Why? |
| Multivariate Analysis | 1 | 2018 | 5440 | 0.02 | Why? |
| Prevalence | 2 | 2021 | 25773 | 0.02 | Why? |
| Diagnostic Tests, Routine | 1 | 2018 | 2643 | 0.02 | Why? |
| Patient Isolation | 1 | 2020 | 3182 | 0.02 | Why? |
| Immunoglobulin G | 2 | 2020 | 21571 | 0.02 | Why? |
| Azithromycin | 1 | 2021 | 3943 | 0.02 | Why? |
| Quality Improvement | 1 | 2018 | 2435 | 0.02 | Why? |
| Survivors | 1 | 2018 | 2619 | 0.02 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2020 | 7868 | 0.02 | Why? |
| Longitudinal Studies | 1 | 2020 | 9893 | 0.02 | Why? |
| Monocytes | 1 | 2017 | 2978 | 0.02 | Why? |
| Kidney | 1 | 2018 | 3648 | 0.02 | Why? |
| Adrenal Cortex Hormones | 1 | 2021 | 6537 | 0.02 | Why? |
| Body Temperature | 1 | 2008 | 875 | 0.02 | Why? |
| Immunoglobulin M | 1 | 2020 | 9091 | 0.02 | Why? |
| RNA, Messenger | 1 | 2017 | 5131 | 0.02 | Why? |
| Cell Line | 1 | 2018 | 12040 | 0.02 | Why? |
| Neutrophils | 1 | 2018 | 5476 | 0.01 | Why? |
| Pulmonary Artery | 1 | 2008 | 803 | 0.01 | Why? |
| Signal Transduction | 1 | 2018 | 7207 | 0.01 | Why? |
| Severity of Illness Index | 2 | 2021 | 48226 | 0.01 | Why? |
| Anxiety | 1 | 2007 | 17311 | 0.01 | Why? |
| Myocardial Infarction | 1 | 2017 | 3361 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 13720 | 0.01 | Why? |
| Spike Glycoprotein, Coronavirus | 2 | 2020 | 37182 | 0.01 | Why? |
| Length of Stay | 1 | 2018 | 11042 | 0.01 | Why? |
| Viral Load | 1 | 2020 | 15850 | 0.01 | Why? |
| Animals | 3 | 2018 | 78931 | 0.01 | Why? |
| Mice | 1 | 2018 | 21357 | 0.01 | Why? |
| Pneumonia | 1 | 2018 | 5652 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2017 | 17020 | 0.01 | Why? |
| Acute Kidney Injury | 1 | 2018 | 5762 | 0.01 | Why? |
| Cohort Studies | 1 | 2021 | 36005 | 0.01 | Why? |
| Hydroxychloroquine | 1 | 2021 | 12447 | 0.01 | Why? |
| Survival Rate | 1 | 2011 | 9206 | 0.01 | Why? |
| Emergency Service, Hospital | 1 | 2021 | 14232 | 0.01 | Why? |
| Thrombosis | 1 | 2017 | 7504 | 0.01 | Why? |
| Stroke | 1 | 2017 | 8839 | 0.01 | Why? |
| Disease Models, Animal | 1 | 2011 | 10998 | 0.01 | Why? |
| RNA, Viral | 1 | 2020 | 32276 | 0.01 | Why? |
| Young Adult | 1 | 2018 | 93724 | 0.01 | Why? |
| Hospitalization | 1 | 2018 | 54280 | 0.01 | Why? |
| Child | 1 | 2008 | 70012 | 0.00 | Why? |